Marina Müller

Learn More
Depot gonadotropin releasing hormone (GnRH) agonist (GnRHa) therapy is the treatment of choice for patients with central precocious puberty (CPP). It is still unclear whether long-term exposure to GnRHa is associated with impaired reproductive function in adulthood. The present study was performed on 46 women, former CPP patients, 12.5+/-3.7 years after the(More)
Visual acuity, contrast sensitivity, and visual fields were examined with and without occluders both in a group of healthy subjects and in a group of patients with field defects (mostly caused by glaucoma). The various results were compared with one another as well as with the results obtained from a group of cataract patients examined before and after(More)
  • 1